Across TCGA pan-cancer cohorts, NPTXR mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NPTXR data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher NPTXR mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NPTXR expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

LSCC and GBM are the cancer types where NPTXR mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Median	III,IV	0.208	0.984	.002	24	view →
GBM	DFS	Tertile	All	0.853	0.621	.015	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NPTXR tumor-vs-normal RNA expression · all NPTXR data types